Appendix E - National Coverage Determinations Manual / HEPATITIS_PANEL

Why This Topic Matters

Coverage policy documents can affect test ordering, claim support, and documentation review. Understanding the scope of the panel and the stated indications helps support compliant use of hepatitis-related laboratory services.

Article Sections

1. Hepatitis Panel/Acute Hepatitis

   Introduces the policy entry for the hepatitis panel and gives the overall clinical context for acute hepatitis evaluation. It also notes the general composition of the panel.

2. Background on Viral Hepatitis

   Provides a broad overview of hepatitis as a disease process and summarizes the major viral types discussed in the policy. The section explains why laboratory testing is relevant in differentiating hepatitis causes.

3. Hepatitis A

   Describes the general laboratory context for hepatitis A and its role in evaluating exposure or prior infection. The discussion is framed around serologic testing and timing of markers.

4. Hepatitis B

   Reviews hepatitis B in the context of serologic markers, infection stages, and related testing concepts. It also mentions additional markers that may be relevant but are outside the panel scope.

5. Hepatitis C

   Summarizes the general laboratory context for hepatitis C and its role in differential diagnosis of liver disease. The discussion includes confirmatory considerations at a high level.

6. Use of the Panel

   Explains the general clinical circumstances in which the panel may be used for diagnostic evaluation. It also notes follow-up testing considerations after an initial negative result.

7. Indications

   Lists the broad coverage indications for using the hepatitis panel. The focus is on suspected liver disease and transplant-related evaluation.

8. Limitations

   States the general limitation on using the full panel once a diagnosis is already established. The section emphasizes that individual tests may be used instead of repeating the complete panel.